Literature DB >> 4426980

The problem of the demonstration of hepatitis B antigen in faeces and bile.

J W Moodie, L M Stannard, A Kipps.   

Abstract

Attempts to detect hepatitis B antigen in faeces and bile should take into account the degradation and disappearance of the surface antigens in an environment containing proteolytic enzymes in the presence of bile salts as in the intestinal lumen. The cores of the Dane particles are much more stable than the surface antigens and these may best be identified by immune electron microscopy using core antibody.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4426980      PMCID: PMC475438          DOI: 10.1136/jcp.27.9.693

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Absence of Au antigen in faeces of patients with Au-positive sera.

Authors:  I D Gust; J Kaldor; M Nastasi
Journal:  Lancet       Date:  1971-04-17       Impact factor: 79.321

2.  S.H. antigen in bile.

Authors:  K A Akdamar; L Maumus; A Cherrie Epps; R Leach; S Warren
Journal:  Lancet       Date:  1971-05-01       Impact factor: 79.321

3.  Immunoagglutination electron microscopic study on virus-like particles and Australia antigen in liver tissue.

Authors:  S N Huang; V Groh
Journal:  Lab Invest       Date:  1973-10       Impact factor: 5.662

4.  Isolation and purification of hepatitis-associated antigen by affinity chromatography with baboon antiserum.

Authors:  W O Grabow; O W Prozesky
Journal:  J Infect Dis       Date:  1973-02       Impact factor: 5.226

5.  Two antigen-antibody systems in serum hepatitis: preparation of immunoglobulins and their reaction with Australia antigen and particles in liver cell homogenates.

Authors:  L M Stannard; A Polson; A Kipps; J R Parker
Journal:  Microbios       Date:  1973 Sep-Oct

6.  Faecal S.H. (Australia) antigen in acute hepatitis.

Authors:  P J Grob; H Jemelka
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

Review 7.  Antigen in infectious hepatitis.

Authors:  A A Ferris
Journal:  Br Med Bull       Date:  1972-05       Impact factor: 4.291

8.  Virus-like particles associated with a faecal antigen from hepatitis patients and with Australia antigen.

Authors:  I D Gust; J Kaldor; G F Cross; M Waugh; A A Ferris
Journal:  Aust J Exp Biol Med Sci       Date:  1971-02

9.  Studies of Australia-SH antigen in sporadic viral hepatitis in London.

Authors:  Y E Cossart; J Vahrman
Journal:  Br Med J       Date:  1970-02-14

10.  Hepatitis B antigen inhibitor in human faeces and intestinal mucosa.

Authors:  M Piazza; G Di Stasio; G Maio; L A Marzano
Journal:  Br Med J       Date:  1973-05-12
View more
  5 in total

1.  Detection of staphylococcal enterotoxin in gastric juice.

Authors:  N Dickie; C E Park; H Robern
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

2.  Inability to detect hepatitis B surface antigen (HBsAg) in the duodenum of HBsAg-positive persons.

Authors:  S V Feinman; B Berris; J C Sinclair; S Wilson; D Wrobel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

3.  Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen.

Authors:  P Karayiannis; D M Novick; A S Lok; M J Fowler; J Monjardino; H C Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

Review 4.  Diagnostic virology using electron microscopic techniques.

Authors:  A M Field
Journal:  Adv Virus Res       Date:  1982       Impact factor: 9.937

5.  Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice.

Authors:  Haruki Komatsu; Ayano Inui; Takeyoshi Murano; Tomoyuki Tsunoda; Tsuyoshi Sogo; Tomoo Fujisawa
Journal:  BMC Res Notes       Date:  2015-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.